Value of Glycogen Synthase 2 in intrahepatic cholangiocarcinoma prognosis assessment and its influence on the activity of cancer cells
Intrahepatic cholangiocarcinoma is the second most common primary liver tumor with increasing incidence worldwide. Metabolic reprogramming caused by metabolic related gene disorders is a prominent hallmark of tumors, among which Glycogen Synthase 2 (GYS2) is the key gene responsible for regulating c...
Saved in:
Main Authors: | Sigen A, Huijun Wu, Xiaodong Wang, Xidong Wang, Jiarui Yang, Long Xia, Yijun Xia |
---|---|
Format: | article |
Language: | EN |
Published: |
Taylor & Francis Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/45a90d9ad03f4d1cacdeca0c0a3144e7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma
by: Serifis N, et al.
Published: (2021) -
TGF-β1 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma
by: Chen,Yijie, et al.
Published: (2015) -
An Inflammation-Index Signature Predicts Prognosis of Patients with Intrahepatic Cholangiocarcinoma After Curative Resection
by: He C, et al.
Published: (2021) -
Immobilization of Glycogen Synthase Kinase-3β Inhibitor on 316L Stainless Steel via Polydopamine to Accelerate Endothelialization
by: Ming Zhang, et al.
Published: (2021) -
A Novel Clinical-Radiomics Model Based on Sarcopenia and Radiomics for Predicting the Prognosis of Intrahepatic Cholangiocarcinoma After Radical Hepatectomy
by: Liming Deng, et al.
Published: (2021)